Sam Waksal's New Biotech Venture Tests Investor Forgiveness ROBERT CYRAN The former ImClone boss who went to prison for an insider trading scandal follows others given second-chances like Donald Trump and John Meriwether, of Long-Term Capital Management. September 25, 2014 at 4:00AM http://nyti.ms/YdM5tr http://nyti.ms/1su8Y9K The New York Times Business Day Biotechnology, Initial Public Offerings

By ROBERT CYRAN via NYT / Eethg. Corps. Inc. / Terrence Herschel G. Business Day http://nyti.ms/YdM5tr Sam Waksal's New Biotech Venture Tests Investor Forgiveness September 25, 2014 at 4:00AM http://nyti.ms/1su8Y9K The New York Times